Invited editorial on "acquired respiratory muscle weakness in critically ill patients: what is the role of mechanical ventilation-induced diaphragm dysfunction?".
Callahan
Leigh A
LA
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D016638:Critical Illness; D003964:Diaphragm / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D018908:Muscle Weakness / Q000201:enzymology / Q000503:physiopathology* / Q000517:prevention & control; D009133:Muscular Atrophy / Q000201:enzymology / Q000503:physiopathology* / Q000517:prevention & control; D018384:Oxidative Stress; D055397:Ventilator-Induced Lung Injury / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology*; D014968:Xanthine Dehydrogenase / Q000378:metabolism; D014969:Xanthine Oxidase / Q000378:metabolism
D000975:Antioxidants; D004791:Enzyme Inhibitors; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase